Virtual health insurance navigation for young adult cancer survivors

A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance Among Young Adult Cancer Survivors

This trial will test a four-session virtual program to help 26–39-year-old cancer survivors understand their health insurance, reduce financial strain, and improve follow-up surveillance.

Quick facts

• Phase: Not applicable
• Study type: Interventional
• Enrollment: 300 (estimated)
• Ages: 26 Years to 45 Years
• Sex: All
• Sponsor: University of Utah (Academic / other)
• Drugs / interventions: chemotherapy, radiation
• Locations: 2 sites (Murray, Utah and 1 other locations)
• Trial ID: NCT05829070 on ClinicalTrials.gov

What this trial studies

This randomized controlled trial will enroll 300 young adult cancer survivors to compare a four-session virtual navigation program (CHAT-S) with usual care. The intervention delivers guided health insurance education and navigation remotely to improve insurance knowledge and help survivors access recommended survivorship services. Outcomes will be measured using self-report surveys combined with electronic health records and claims data to capture insurance knowledge, financial burden, and surveillance for recurrence. An economic evaluation including cost-effectiveness and budget impact analyses will examine sustainability and potential system-level value.

Who should consider this trial

Good fit: Adults aged 26–45 (preferably 26–39) diagnosed with breast, testicular, lymphoma, sarcoma, or colorectal cancer who completed initial treatment within the past year, are patients at University of Utah/Huntsman or Intermountain Healthcare, and speak English.

Not a fit: People who do not speak English, lack phone or video-capable devices, have developmental delays that prevent participation, live outside the participating health systems, or have cancer types not listed are unlikely to benefit from this intervention.

Why it matters

Potential benefit: If successful, the program could help young survivors better use their insurance, face lower out-of-pocket costs, and be more likely to receive guideline-recommended surveillance.

How similar studies have performed: Pilot implementations of this navigation program and an adapted childhood-survivor version demonstrated feasibility, acceptability, and preliminary efficacy, but large randomized evidence is still pending.

Eligibility criteria

Inclusion Criteria:

Participants are eligible for this study if they:

1. Were diagnosed with breast, testicular, lymphoma, sarcoma, and colorectal cancer,
2. Are between the ages of 26 to 45 years (preferably between 26-39, but no older than 45),
3. Have completed initial treatment (i.e., radiation, chemotherapy, or surgery) within the past year,
4. Are a patient at the University of Utah/Huntsman Cancer Institute or Intermountain Healthcare, and
5. Speak English.

Exclusion Criteria:

Potential participants will be excluded if they:

1. Are unable to participate due to developmental delay, and
2. Speak a language other than English, and
3. Unable to participate through either phone or a video capable computer or mobile device (e.g., smartphone, laptop, etc.).

Where this trial is running

Murray, Utah and 1 other locations

• Intermountain Health — Murray, Utah, United States (Recruiting)
• University of Utah — Salt Lake City, Utah, United States (Recruiting)

Study contacts

• Study coordinator: Amy Chevrier, BS

Conditions Cancer